Search Results - "Palmieri, Giovannella"

Refine Results
  1. 1

    Hepatocellular carcinoma: Will novel targeted drugs really impact the next future? by Montella, Liliana, Palmieri, Giovannella, Addeo, Raffaele, Del Prete, Salvatore

    Published in World journal of gastroenterology : WJG (21-07-2016)
    “…Cancer treatment has been revolutionized by the advent of new molecular targeted and immunotherapeutic agents. Identification of the role of tumor angiogenesis…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Extraskeletal Ewing's sarcoma of the mediastinum: Case report by Caltavituro, Aldo, Buonaiuto, Roberto, Salomone, Fabio, Morra, Rocco, Pietroluongo, Erica, De Placido, Pietro, Tortora, Marianna, Peddio, Annarita, Picozzi, Fernanda, Ottaviano, Margaret, Marino, Mirella, De Placido, Sabino, Palmieri, Giovannella, Giuliano, Mario

    Published in Frontiers in oncology (26-01-2023)
    “…Ewing sarcoma (ES) represents the second most common malignant bone tumor in children and young adults. ES is not a frequent finding in sites different from…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    A comprehensive outlook on intracerebral therapy of malignant gliomas by Buonerba, Carlo, Di Lorenzo, Giuseppe, Marinelli, Alfredo, Federico, Piera, Palmieri, Giovannella, Imbimbo, Martina, Conti, Pio, Peluso, Gianfranco, De Placido, Sabino, Sampson, John H

    Published in Critical reviews in oncology/hematology (01-10-2011)
    “…Abstract Glioblastoma multiforme (GBM) is the most frequent and aggressive malignant glioma (MG), with a median survival time of 12–15 months, despite current…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling by Montella, Liliana, Ottaviano, Margaret, Riccio, Vittorio, Picozzi, Fernanda, Facchini, Gaetano, Insabato, Luigi, Giuliano, Mario, Palmieri, Giovannella

    Published in Biomedicines (24-11-2021)
    “…Langerhans cell histiocytosis (LCH) is a rare disease that has a variable clinical presentation and unpredictable behavior. Until recently, therapeutic options…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Peg-filgrastim and cabazitaxel in prostate cancer patients by Di Lorenzo, Giuseppe, DʼAniello, Carmine, Buonerba, Carlo, Federico, Piera, Rescigno, Pasquale, Puglia, Livio, Ferro, Matteo, Bosso, Davide, Cavaliere, Carla, Palmieri, Giovannella, Sonpavde, Guru, De Placido, Sabino

    Published in Anti-cancer drugs (01-01-2013)
    “…To determine the impact of prophylaxis with granulocyte-colony stimulating growth factor (G-CSF) on the risk of febrile neutropenia in a cohort of patients…”
    Get full text
    Journal Article
  19. 19

    Cetuximab is an active treatment of metastatic and chemorefractory thymoma by Palmieri, Giovannella, Marino, Mirella, Salvatore, Marco, Budillon, Alfredo, Meo, Giuseppina, Caraglia, Michele, Montella, Liliana

    Published in Frontiers in bioscience (01-01-2007)
    “…Advanced chemorefractory thymic epithelial tumors still represent a challenge in clinical oncology. A rationale-based therapeutic approach targeting a key…”
    Get full text
    Journal Article
  20. 20

    Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis by Montella, Liliana, Merola, Carmela, Merola, Geraldina, Petillo, Luigi, Palmieri, Giovannella

    Published in Journal of bone and mineral metabolism (01-01-2009)
    “…Langerhans cell histiocytosis (LCH) is a rare disease, probably an atypical myeloproliferative syndrome, with variable clinical presentation and behavior. In…”
    Get full text
    Journal Article